FDA is investigating Zecuity sumatriptan patch for reports of serious burns

The Food and Drug Administration is evaluating patient reports of serious burns and potential permanent scarring that have occurred with the use of the Zecuity patch (sumatriptan iontophoretic...
Source: Family Practice News - Category: Primary Care Source Type: news